Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany-Reference-Cited by-同舟云学术

Aflibercept for Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in Germany

Published:2018-06 Issue:6 Volume:2 Page:539-549
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Framme Carsten,Eter Nicole,Hamacher Thomas,Hasanbasic Zoran,Jochmann Claudia,Johnson Kristian T.,Kahl Miriam,Sachs Helmut,Schilling Harald,Thelen Ulrich,Wiedemann Peter,Wachtlin Joachim

Publisher

Elsevier BV

Subject

Ophthalmology

Reference33 articles.

1. Important causes of visual impairment in the world today;Congdon;JAMA,2003

2. Anti-VEGF compounds in the treatment of neovascular age related macular degeneration;Campa;Curr Drug Targets,2011

3. [Delayed treatment initiation of more than 2 weeks. Relevance for possible gain of visual acuity after anti-VEGF therapy under real life conditions (interim analysis of the prospective OCEAN study)];Ziemssen;Ophthalmologe,2016

4. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration;Holz;Br J Ophthalmol,2015

5. First-year visual acuity outcomes of providing aflibercept according to the VIEW study protocol for age-related macular degeneration;Talks;Ophthalmology,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term results of the treatment of patients with exudative age-related macular degeneration during the COVID-19 pandemic;Archivos de la Sociedad Española de Oftalmología (English Edition);2024-07

2. Resultados a largo plazo del tratamiento de los pacientes con degeneración macular asociada a la edad exudativa durante la pandemia por COVID-19;Archivos de la Sociedad Española de Oftalmología;2024-07

3. XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration;Ophthalmology and Therapy;2024-01-10

4. The first Russian register of patients with neovascular age-related macular degeneration: a real-world clinical study;Russian Ophthalmological Journal;2023-12-19

5. Five-year outcome of aflibercept intravitreal injection in naïve patients with neovascular age-related macular degeneration using a modified treat-and-extend regimen: Results from a prospective observational study;Taiwan Journal of Ophthalmology;2023